Timing of Periodontal Re-evaluation After Non-surgical Periodontal Therapy

February 11, 2022 updated by: University of Turin, Italy

Impact of Timing of Re-evaluation After Non-surgical Periodontal Therapy on Clinical Parameters and Decision-making. A Prospective Clinical Trial

Literature on non surgical periodontal therapy (NSPT) shows lack of clarity in reporting information on re-evaluation timing and clinical response. If the re-evaluation was done shortly after NSPT, this is also likely to have an influence on the surgical treatment plan. The aim of this prospective clinical trial is to investigate the effect of re-evaluation timing at 1-3-6 months after NSPT in terms of pocket closure, PD reduction, comprehensive treatment plan, and costs for the patient.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

28

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Turin, Italy, 10126
        • CIR Dental School

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Periodontitis stage III-IV
  • Full-mouth plaque score (FMPS) < 25% at the 1-month re-evaluation
  • Full-mouth bleeding score (FMBS) < 25% at the 1-month re-evaluation
  • Signed informed consent

Exclusion criteria

  • Age < 18 yo
  • Pregnancy or lactation
  • Heavy smokers (>10 die)
  • Conditions or diseases influencing periodontal healing
  • Patients that cannot complete the 6 months follow-up

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Non-surgical periodontal treatment NSPT

Conventional staging debridement (CSD) according to the severity of periodontal disease in 2 to 4 appointments at day 0, 7, 14 and 21.

Supra and subgingival scaling and polishing will be performed by the use of manual and ultrasonic instruments and oral hygiene instructions will be given. Patients will be instructed to use interdental brushes with appropriate size interdental brushes or dental floss when interdental embrasures will not allow for interdental brushing.

Conventional staging debridement (CSD) according to the severity of periodontal disease in 2 to 4 appointments at day 0, 7, 14 and 21.

Supra and subgingival scaling and polishing will be performed by the use of manual and ultrasonic instruments and oral hygiene instructions will be given. Patients will be instructed to use interdental brushes with appropriate size interdental brushes or dental floss when interdental embrasures will not allow for interdental brushing.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in pocket closure % (0 - 100 % with higher percentage indicating better status)
Time Frame: [Time Frame: Baseline, 1 month, 3 months and 6 months after the completion of the therapy.]
Percentage of pockets ≥ 5 mm that converted to ≤4 mm at the completion of NSPT
[Time Frame: Baseline, 1 month, 3 months and 6 months after the completion of the therapy.]

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Full Mouth Plaque Score (FMPS%) (0 - 100 % with higher percentage indicating worse status)
Time Frame: [Time Frame: Baseline, 1 month, 3 months and 6 months after the completion of the therapy.]
Percentage of full mouth plaque score considering 6 sited for each tooth.
[Time Frame: Baseline, 1 month, 3 months and 6 months after the completion of the therapy.]
Change in Probing Pocket Depth (PD) (0 - 15 mm with higher values indicating worse outcomes.
Time Frame: [Time Frame: Baseline, 1 month, 3 months and 6 months after the completion of the therapy.]
The distance between the cementoenamel junction (CEJ) and the base of the pocket.
[Time Frame: Baseline, 1 month, 3 months and 6 months after the completion of the therapy.]
Change in Clinical Attachment Level (CAL) (0 - 15 mm with higher values indicating worse outcomes.
Time Frame: [Time Frame: Baseline, 1 month, 3 months and 6 months after the completion of the therapy.]
The sum of Probing pocket depth (PD, mm) and Recession (Rec, mm)
[Time Frame: Baseline, 1 month, 3 months and 6 months after the completion of the therapy.]
Monetary cost for the treatment plan in €
Time Frame: [Time Frame: 1 month, 3 months and 6 months after the completion of the therapy.]
Cost in € for the proposed treatment plan for patient at each re-evaluation timing based on the Italian Dental Association survey of charges for periodontal services for general dentists and periodontists.
[Time Frame: 1 month, 3 months and 6 months after the completion of the therapy.]

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2021

Primary Completion (Actual)

October 15, 2021

Study Completion (Actual)

January 10, 2022

Study Registration Dates

First Submitted

March 23, 2021

First Submitted That Met QC Criteria

March 29, 2021

First Posted (Actual)

April 1, 2021

Study Record Updates

Last Update Posted (Actual)

March 2, 2022

Last Update Submitted That Met QC Criteria

February 11, 2022

Last Verified

January 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • UTurin02

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Periodontitis

Clinical Trials on Procedure/Surgery: Non Surgical Periodontal Therapy

3
Subscribe